RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Fintel reports that on January 9, 2025, RBC Capital upgraded their outlook for Canadian Imperial Bank of Commerce (NYSE:CM) ...

In the last two years, it’s happened for the fifth time. The S&P 500 was up 26% in 2023 and 25% in 2024, for the best ...

RBC Capital initiated coverage of Amentum (AMTM) with a Sector Perform rating and $24 price target Amentum is a leading government services ...

RBC Capital analyst Gregory Renza maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) on January 7 and set a price ...

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...